Owkin
Deirdre De Steno PhD MBA currently serves as the Senior Vice President and Head of Commercial at Owkin, leading a team focused on commercial sales, solutions, and alliance management, while partnering with global pharmaceutical and biotech companies. Prior experience includes Vice President of Pharma Business Development at Owkin, where Deirdre directed a US-based team responsible for end-to-end drug development services. Previous roles encompass Vice President of BioPharma Partnerships at PathAI, Head of Diagnostics Global Medical Affairs at Grifols, and several positions at Bristol-Myers Squibb and AstraZeneca related to oncology diagnostics. Deirdre holds a PhD in Pharmacology from Columbia University and an MBA from NYU Stern School of Business, along with a Master’s in Pharmacology from the University of Maryland Baltimore and a Bachelor’s in Biochemistry from Bucknell University.
This person is not in the org chart
This person is not in any teams
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.